Correlation Between Werewolf Therapeutics and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Werewolf Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Mineralys Therapeutics,.
Diversification Opportunities for Werewolf Therapeutics and Mineralys Therapeutics,
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Werewolf and Mineralys is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and Mineralys Therapeutics,
Given the investment horizon of 90 days Werewolf Therapeutics is expected to generate 1.65 times more return on investment than Mineralys Therapeutics,. However, Werewolf Therapeutics is 1.65 times more volatile than Mineralys Therapeutics, Common. It trades about 0.02 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.0 per unit of risk. If you would invest 226.00 in Werewolf Therapeutics on November 1, 2024 and sell it today you would lose (91.50) from holding Werewolf Therapeutics or give up 40.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Werewolf Therapeutics vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Werewolf Therapeutics |
| Mineralys Therapeutics, |
Werewolf Therapeutics and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Werewolf Therapeutics and Mineralys Therapeutics,
The main advantage of trading using opposite Werewolf Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
| Mineralys Therapeutics, vs. Griffon | Mineralys Therapeutics, vs. RCI Hospitality Holdings | Mineralys Therapeutics, vs. Summit Materials | Mineralys Therapeutics, vs. EastGroup Properties |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |